Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 14380133Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2025 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2025
Linked Award Amount
$3M
Full award amounts, FY2025
Award Records
7
Records listing this PI
Award-Linked Rank
#3,326
By linked amount among FY2025 PIs
Earliest Year Loaded
2025
ScienceDex PI coverage
Award data coverage
ScienceDex currently has one fiscal year of PI ranking data for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2025): $3M in linked award amounts across 7 award records · Award-linked rank #3326.
FY2025 award records by amount
NIH award records listing Craig Thomas as a PI. Multi-PI records show the full award amount for context.
- 1ZIATR000047-11ZIAHTS enabled examination of drug combinations$1.2Maward amount
- 1ZIATR000562-01ZIABioactive small molecule development- Ketamine metabolite program$455.9Kaward amount
- 1ZIATR000563-01ZIABioactive small molecule development- LATS program$455.9Kaward amount
- 1ZIATR000564-01ZIABioactive small molecule development- PKM2 program$455.9Kaward amount
- 1ZIATR000473-03ZIADisease model design and evaluation$152Kaward amount
- 1ZIATR000472-03ZIABioactive small molecule development- IRAK-FLT3 program$152Kaward amount
- 1ZIATR000043-11ZIANovel small molecule library development$152Kaward amount
Award organization
Organizations that administered FY2025 awards listing Craig Thomas as a PI.
FY2025 award administered by National Center for Advancing Translational Sciences ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2025First NIH AwardNational Center for Advancing Translational Sciences
- 2025$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #3326
- 2025Entered Top 25% NationallyRanked #3326